| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human GUCY2D recombinant protein (Position: D65-S1103) was used as the immunogen for the GUCY2D antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
GUCY2D Antibody / Guanylate cyclase 2D is an antibody targeting GUCY2D. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, ELISA.
Key elements and design rationale
- Target: GUCY2D.
- Immunogen: E.coli-derived human GUCY2D recombinant protein (Position: D65-S1103) was used as the immunogen for the GUCY2D antibody..
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
GUCY2D antibody recognizes Guanylate cyclase 2D, a membrane-bound guanylyl cyclase that plays an essential role in the human visual system. Encoded by the GUCY2D gene located on chromosome 17p13.1, this protein is also referred to as retinal guanylyl cyclase 1 (RetGC-1).
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
